These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 26643668)
1. CCL15 overexpression predicts poor prognosis for hepatocellular carcinoma. Li Y; Yu HP; Zhang P Hepatol Int; 2016 May; 10(3):488-92. PubMed ID: 26643668 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B Virus X Protein Modulates Chemokine CCL15 Upregulation in Hepatocellular Carcinoma. Li Y; Wang C; Zhao T; Cui R; Hu L; Chang L; Wei X; Zhang J; Li Y Anticancer Agents Med Chem; 2021 Oct; 21(16):2198-2203. PubMed ID: 33653254 [TBL] [Abstract][Full Text] [Related]
3. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
4. [Biological function explore of protein CCL15 in HCC cell lines]. Li YG; Zhang P Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):372-6. PubMed ID: 22971284 [TBL] [Abstract][Full Text] [Related]
5. CCL15/CCR1 axis is involved in hepatocellular carcinoma cells migration and invasion. Li Y; Wu J; Zhang P Tumour Biol; 2016 Apr; 37(4):4501-7. PubMed ID: 26501423 [TBL] [Abstract][Full Text] [Related]
6. Chemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Hepatocellular Carcinoma. Gao Y; Zhou Z; Lu S; Huang X; Zhang C; Jiang R; Yao A; Sun B; Wang X Stem Cells; 2016 Apr; 34(4):1112-22. PubMed ID: 26763650 [TBL] [Abstract][Full Text] [Related]
7. Importance of SALL4 in the development and prognosis of hepatocellular carcinoma. Yin F; Han X; Yao SK; Wang XL; Yang HC World J Gastroenterol; 2016 Mar; 22(9):2837-43. PubMed ID: 26973422 [TBL] [Abstract][Full Text] [Related]
8. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis. Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973 [TBL] [Abstract][Full Text] [Related]
9. CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma. Liu LZ; Zhang Z; Zheng BH; Shi Y; Duan M; Ma LJ; Wang ZC; Dong LQ; Dong PP; Shi JY; Zhang S; Ding ZB; Ke AW; Cao Y; Zhang XM; Xi R; Zhou J; Fan J; Wang XY; Gao Q Hepatology; 2019 Jan; 69(1):143-159. PubMed ID: 30070719 [TBL] [Abstract][Full Text] [Related]
10. Des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma and liver cirrhosis. Inagaki Y; Xu HL; Hasegawa K; Aoki T; Beck Y; Sugawara Y; Tang W; Kokudo N J Dig Dis; 2011 Dec; 12(6):481-8. PubMed ID: 22118699 [TBL] [Abstract][Full Text] [Related]
11. Tissue microarray-based study of hepatocellular carcinoma validating SPIB as potential clinical prognostic marker. Ho YJ; Lin YM; Huang YC; Yeh KT; Lin LI; Lu JW Acta Histochem; 2016 Jan; 118(1):38-45. PubMed ID: 26610895 [TBL] [Abstract][Full Text] [Related]
12. Increased expression of annexin A1 predicts poor prognosis in human hepatocellular carcinoma and enhances cell malignant phenotype. Lin Y; Lin G; Fang W; Zhu H; Chu K Med Oncol; 2014 Dec; 31(12):327. PubMed ID: 25412936 [TBL] [Abstract][Full Text] [Related]
13. Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma. Qin HX; Nan KJ; Yang G; Jing Z; Ruan ZP; Li CL; Xu R; Guo H; Sui CG; Wei YC World J Gastroenterol; 2005 May; 11(18):2709-13. PubMed ID: 15884108 [TBL] [Abstract][Full Text] [Related]
14. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma. Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813 [TBL] [Abstract][Full Text] [Related]
15. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma]. Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of synergistic hexokinase-2 and beta2-adrenergic receptor expression in human hepatocelluar carcinoma after curative resection. Zhang ZF; Feng XS; Chen H; Duan ZJ; Wang LX; Yang D; Liu PX; Zhang QP; Jin YL; Sun ZG; Liu H BMC Gastroenterol; 2016 Jun; 16(1):57. PubMed ID: 27255554 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma. Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of neuroepithelial transforming protein 1 in hepatocellular carcinoma. Ye K; Wang Z; Zhang G; Liang S J Invest Surg; 2010 Jun; 23(3):163-9. PubMed ID: 20590388 [TBL] [Abstract][Full Text] [Related]
19. Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma. Zhang X; Li N; Li X; Zhao W; Qiao Y; Liang L; Ding Y J Gastroenterol Hepatol; 2012 Jun; 27(6):1117-25. PubMed ID: 22168621 [TBL] [Abstract][Full Text] [Related]
20. High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma. He C; Xu J; Zhang J; Xie D; Ye H; Xiao Z; Cai M; Xu K; Zeng Y; Li H; Wang J Hum Pathol; 2012 Sep; 43(9):1425-35. PubMed ID: 22406368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]